We are live on ! Find out more
Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $481B
1-Year Est. Return 30.42%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+30.42%
3 Year Est. Return
+88.16%
5 Year Est. Return
+120.13%
10 Year Est. Return
+468.8%
AUM
$134B
AUM Growth
+$5.5B
Cap. Flow
+$3.82B
Cap. Flow %
2.85%
Top 10 Hldgs %
8.43%
Holding
3,643
New
102
Increased
2,063
Reduced
953
Closed
48

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$344M
2
INTC icon
Intel
INTC
+$219M
3
AAPL icon
Apple
AAPL
+$206M
4
PFE icon
Pfizer
PFE
+$201M
5
JPM icon
JPMorgan Chase
JPM
+$178M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$173M
2
BAC icon
Bank of America
BAC
+$171M
3
C icon
Citigroup
C
+$111M
4
VPHM
VIROPHARMA INC
VPHM
+$103M
5
LEAP
LEAP WIRELESS INTERNATIONAL INC NEW
LEAP
+$48.6M

Sector Composition

Rank Sector Weight
1 Financials 18.88%
2 Industrials 13.29%
3 Energy 11.48%
4 Technology 10.2%
5 Healthcare 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
3551
Heron Therapeutics
HRTX
$94.1M
$8K ﹤0.01%
+580
New +$7.75K
IRWD icon
3552
Ironwood Pharmaceuticals
IRWD
$614M
$8K ﹤0.01%
+757
New +$8.51K
GSS
3553
DELISTED
Golden Star Resources Ltd.
GSS
$8K ﹤0.01%
2,760
– –
VOYA icon
3554
Voya Financial
VOYA
$9.09B
$7K ﹤0.01%
+206
New +$7.31K
ECYT
3555
DELISTED
Endocyte, Inc. Common Stock
ECYT
$7K ﹤0.01%
300
-149,469
-100% -$2.17M
WAC
3556
DELISTED
Walter Investment Mgt Corp
WAC
$7K ﹤0.01%
250
-134
-35% -$4.02K
DRWI
3557
DELISTED
DragonWave Inc
DRWI
$7K ﹤0.01%
196
– –
GNOW
3558
DELISTED
AMERICAN CARESOURCE HLDGS INC COM STK NEW (DE)
GNOW
$7K ﹤0.01%
3,329
– –
EXFO
3559
DELISTED
EXFO INC.
EXFO
$6K ﹤0.01%
1,300
– –
CALD
3560
DELISTED
Callidus Software, Inc.
CALD
$6K ﹤0.01%
500
– –
HDY
3561
DELISTED
HYPERDYNAMICS CORP (NEW)
HDY
$6K ﹤0.01%
3,682
-2,300
-38% -$11K
CARV
3562
DELISTED
Carver Bancorp
CARV
$5K ﹤0.01%
400
– –
FSM icon
3563
Fortuna Silver Mines
FSM
$2.66B
$5K ﹤0.01%
1,312
– –
FUSB icon
3564
First US Bancshares
FUSB
$93.7M
$5K ﹤0.01%
600
– –
LTRX icon
3565
Lantronix
LTRX
$239M
$5K ﹤0.01%
2,378
– –
IMMU
3566
DELISTED
Immunomedics Inc
IMMU
$5K ﹤0.01%
1,300
-365,188
-100% -$1.81M
GHDX
3567
DELISTED
Genomic Health, Inc.
GHDX
$5K ﹤0.01%
200
-64
-24% -$1.84K
ELGX
3568
DELISTED
Endologix Inc
ELGX
$5K ﹤0.01%
40
– –
SBY
3569
DELISTED
Silver Bay Realty Trust Corp.
SBY
$5K ﹤0.01%
+297
New +$4.74K
RXII
3570
DELISTED
GALENA BIOPHARMA INC COM
RXII
$5K ﹤0.01%
1,913
– –
VVUS
3571
DELISTED
Vivus Inc
VVUS
$5K ﹤0.01%
90
-20
-18% -$1.42K
OREX
3572
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5K ﹤0.01%
70
– –
ALTO icon
3573
Alto Ingredients
ALTO
$358M
$4K ﹤0.01%
264
– –
BCRX icon
3574
BioCryst Pharmaceuticals
BCRX
$2.35B
$4K ﹤0.01%
379
– –
STB
3575
DELISTED
Student Transportation Inc
STB
$4K ﹤0.01%
700
– –
141 142
143
144 145

Similar funds

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Dimensional Fund Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Dimensional Fund Advisors held 3,643 positions worth $134B, up 4.3% from $128B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Trading was light in Q1 2014: portfolio turnover was 4.1%. Dimensional Fund Advisors opened 102 new positions and exited 48, leaving the 3,643-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Energy.

  • Dimensional Fund Advisors's largest Q1 2014 buy was SIZMEK INC COM STK (DE): 1,323,230 shares worth $14.1M.
  • Dimensional Fund Advisors added most to ExxonMobil in Q1 2014, an estimated $344M increase.
  • Dimensional Fund Advisors's biggest Q1 2014 reduction was Vodafone, cutting an estimated $173M.
  • Dimensional Fund Advisors fully exited VIROPHARMA INC in Q1 2014, selling an estimated $103M.
  • Dimensional Fund Advisors's ten largest holdings make up 8.4% of its $134B portfolio in Q1 2014.
  • Dimensional Fund Advisors opened 102 new positions and closed 48 in Q1 2014.
  • Dimensional Fund Advisors's portfolio value rose 4.3% quarter-over-quarter to $134B.

Based on Dimensional Fund Advisors's 13F filing for Q1 2014, filed 14 May 2014.